当前位置: 首页 > 文章 > 武陵山片区中药材规范化栽培(GAP)现状及生物医药产业发展对策 江西农业学报 2013,25 (5) 142-145
Position: Home > Articles > 武陵山片区中药材规范化栽培(GAP)现状及生物医药产业发展对策 Acta Agriculturae Jiangxi 2013,25 (5) 142-145

武陵山片区中药材规范化栽培(GAP)现状及生物医药产业发展对策

作  者:
孙志国;钟儒刚;刘之杨;黄莉敏;王树婷;张敏;熊晚珍
单  位:
湖北科技学院鄂南文化研究中心
关键词:
武陵山片区;中药材;GAP认证;生物医药产业;产业扶贫
摘  要:
通过对武陵山片区中药材GAP认证与生物医药产业的研究,提出了相应的发展对策,并建议:(1)加强中药材GAP种植基地建设;(2)加强GAP、GMP、GSP 3种国家药品认证;(3)重点建设国家地理标志中药材的GAP生产基地;(4)加强扶贫攻坚规划中药材基地的GAP认证;(5)保护与传承中药文化遗产;(6)加快中药材品牌化建设步伐;(7)发展少数民族医药与国家地理标志中药材的生物医药产业.
单  位:
Centre for Cultural Studies on Southern Hubei Province,Hubei University of Science and Technology,Xianning 437100,China
关键词:
Wuling mountainous area%Chinese crude drugs%GAP certification%Biological medicine industry%Industry poverty alleviation
摘  要:
This article studied the certification of good agricultural practice(GAP) for Chinese crude drugs and biological medicine industry in Wuling mountainous area,and proposed the corresponding developmental countermeasures.It was recommended that:(1) to strengthen the cultivation base construction of GAP for Chinese crude drugs;(2) to strengthen the certification of GAP,GMP and GSP for national drugs;(3) to focus on the base construction of GAP for Chinese crude drugs with national geographical indication;(4) to strengthen the GAP certification of Chinese crude drug base in the poverty alleviation plan area;(5) to protect and inherit the cultural heritage of traditional Chinese medicine;(6) to accelerate the brand construction of Chinese crude drugs;(7) to develop the minority medicine and the biological medicine industry of Chinese crude drugs with national geographical indication.

相似文章

计量
文章访问数: 9
HTML全文浏览量: 0
PDF下载量: 0

所属期刊

推荐期刊